Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$187.2K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Jun 30 | APTO | Aptose Biosciences Inc. | DTOISS◆ | 3,333 | — | — | — | Open the original filing on SEC.gov |
| Jun 30 | APTO | Aptose Biosciences Inc. | DTOISS | 17,000 | $1.72 | $29.2K | -100.0% | Open the original filing on SEC.gov |
| Jun 16 | APRE | Aprea Therapeutics, Inc. | AGRANT◆ | 12,555 | — | — | — | Open the original filing on SEC.gov |
| Jun 16 | APRE | Aprea Therapeutics, Inc. | AGRANT | 3,135 | — | — | +6.9% | Open the original filing on SEC.gov |
| Jun 1 | ONCY | Oncolytics Biotech INC | AGRANT◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | ONCY | Oncolytics Biotech INC | PBUY | 40,000 | $0.8466 | $33.9K | +7.6% | Open the original filing on SEC.gov |
| Feb 11 | ONCY | Oncolytics Biotech INC | PBUY | 60,000 | $0.8265 | $49.6K | +12.8% | Open the original filing on SEC.gov |
| Jan 16 | ONCY | Oncolytics Biotech INC | PBUY | 100,000 | $1.04 | $103.8K | +27.3% | Open the original filing on SEC.gov |
| Jun 5, 2025 | APRE | Aprea Therapeutics, Inc. | AGRANT◆ | 4,185 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | APRE | Aprea Therapeutics, Inc. | AGRANT | 1,045 | — | — | +2.3% | Open the original filing on SEC.gov |